Does systemic acquired resistance (SAR) control HLB disease development?

PIs: Jim Graham

Collaborators: Tim Gottwald; Michael Irey;

Reports:

Funding sources:

  • Funded by: CRDF
  • Budget: $59,975.00
  • Start date: 2010-07-01
  • Stop date: 2011-06-30
  • Status: APPROVED